Lingyan Yu
Impact in
- Biological Psychiatry top 10%
- Neurology top 10%
- Intracerebral and Subarachnoid Hemorrhage Research
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- RNA modifications and cancer 3
- Kruppel-like factors research 2
-
- Epilepsy research and treatment 8
- Co-authors
- Zhenwei Yu (26 shared papers)Jiping Tang (6 shared papers)John H. Zhang (6 shared papers)Derek Nowrangi (3 shared papers)Tai Xiang Lu (4 shared papers)Jing Du (7 shared papers)Xiaoyi Sun (1 shared paper)Tian Wang (3 shared papers)
- Journals
- Frontiers in Pharmacology (8 papers)PLoS ONE (3 papers)Frontiers in Psychiatry (2 papers)BMJ Open (2 papers)Journal of Neuroinflammation (2 papers)
- Partner nations
- ChinaUnited States
In The Last Decade
Lingyan Yu
60 papers receiving 870 citations
Lingyan Yu's Hit Papers
Peers
Comparison fields: 5 of 98
- Biological Psychiatry 30
- Neurology 111
- Neurology 56
- Pharmaceutical Science 42
- Applied Microbiology and Biotechnology 9
Countries citing papers authored by Lingyan Yu
This map shows the geographic impact of Lingyan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyan Yu more than expected).
Fields of papers citing papers by Lingyan Yu
This network shows the impact of papers produced by Lingyan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyan Yu. The network helps show where Lingyan Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingyan Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 90 | |
| 2 | 2023 | 80 | |
| 3 | 2016 | 72 | |
| 4 | 2017 | 61 | |
| 5 | Targeting epigenetic and post-translational modifications of NRF2: key regulatory factors in disease treatment Hit paper breakdown → | 2025 | 43 |
| 6 | 2017 | 43 | |
| 7 | 2020 | 40 | |
| 8 | 2024 | 31 | |
| 9 | 2020 | 27 | |
| 10 | 2020 | 24 | |
| 11 | 2018 | 24 | |
| 12 | 2018 | 21 | |
| 13 | 2024 | 21 | |
| 14 | 2011 | 21 | |
| 15 | 2020 | 21 | |
| 16 | 2010 | 20 | |
| 17 | 2017 | 18 | |
| 18 | 2022 | 17 | |
| 19 | 2021 | 17 | |
| 20 | 2025 | 16 |
About Lingyan Yu
Lingyan Yu is a scholar working on Molecular Biology, Psychiatry and Mental health, Pharmacology, Neurology and Epidemiology, having authored 67 papers that have together received 877 indexed citations. Recurring topics across this work include Epilepsy research and treatment (8 papers), Intracerebral and Subarachnoid Hemorrhage Research (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Ferroptosis and cancer prognosis (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), RNA modifications and cancer (3 papers), Kruppel-like factors research (2 papers) and Herpesvirus Infections and Treatments (2 papers). The work is most often cited by research in Biological Psychiatry (30 citations), Neurology (111 citations), Neurology (56 citations), Pharmaceutical Science (42 citations) and Applied Microbiology and Biotechnology (9 citations). Lingyan Yu has collaborated with scholars based in China and United States. Frequent co-authors include Zhenwei Yu, Jiping Tang, John H. Zhang, Derek Nowrangi, Tai Xiang Lu, Jing Du, Xiaoyi Sun, Tian Wang, Yuanyuan Lv and Haibin Dai. Their work appears in journals such as Frontiers in Pharmacology, PLoS ONE, Frontiers in Psychiatry, BMJ Open and Journal of Neuroinflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.